Loading chart…
PRE-MARKET
Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products.
Divi's Laboratories Limited (DIVISLAB) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The DIVISLAB share price is ₹10,320.50 (+1.78% today), with a market capitalisation of ₹2.74T and a price-to-earnings (P/E) ratio of 93.6. MarketRipple tracks the DIVISLAB investment thesis, the ripple-chain impact of market events on Divi's Laboratories Limited, and the Healthcare sector outlook.
Open
₹10,130.00
High
₹10,320.50
Low
₹10,040.50
Prev. Close
₹10,140.50
52W High
₹10,320.50
52W Low
₹5,647.50
Day range
₹10,040.50–₹10,320.50
52-week range
₹5,647.50–₹10,320.50
Volume
885K
P/E
93.6
ROE
15.3%
D/E
0.00
Margin
26.0%
Divi's Laboratories Limited (NSE: DIVISLAB) is currently trading at ₹10,320.50 (+1.78%).
Divi's Laboratories Limited's market capitalization is ₹2.74T.
Divi's Laboratories Limited's price-to-earnings (P/E) ratio is 93.6.
Divi's Laboratories Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Divi's Laboratories Limited currently reads neutral, based on 28 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.